Terms: = Leukemia AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869 AND Treatment
6 results:
1. Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors.
Braggio DA; Costas C de Faria F; Koller D; Jin F; Zewdu A; Lopez G; Batte K; Casadei L; Welliver M; Horrigan SK; Han R; Larson JL; Strohecker AM; Pollock RE
PLoS One; 2022; 17(10):e0276047. PubMed ID: 36240209
[TBL] [Abstract] [Full Text] [Related]
2. miRNA-222-3p enhances the proliferation and suppresses the apoptosis of acute myeloid leukemia cells by targeting axin2 and modulating the Wnt/β-catenin pathway.
Liu Z; Zhong L; Dan W; Chu X; Liu C; Luo X; Zhang Z; Lu Y; Wan P; Wang X; Liu B
Biochem Biophys Res Commun; 2022 Sep; 620():83-91. PubMed ID: 35780585
[TBL] [Abstract] [Full Text] [Related]
3. AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia.
Fatima M; Kakar SJ; Adnan F; Khan K; Mian AA; Khan D
BMC Cancer; 2021 Jun; 21(1):713. PubMed ID: 34140003
[TBL] [Abstract] [Full Text] [Related]
4. Wnt Signalling in Acute Myeloid Leukaemia.
Gruszka AM; Valli D; Alcalay M
Cells; 2019 Nov; 8(11):. PubMed ID: 31703382
[TBL] [Abstract] [Full Text] [Related]
5. Baicalein suppresses the proliferation of acute T-lymphoblastic leukemia Jurkat cells by inhibiting the Wnt/β-catenin signaling.
Liu X; Liu S; Chen J; He L; Meng X; Liu S
Ann Hematol; 2016 Oct; 95(11):1787-93. PubMed ID: 27506924
[TBL] [Abstract] [Full Text] [Related]
6. [Genetic Polymorphisms in Wnt Signaling Pathway and Acute leukemia].
Zhang LJ; Zhou J; Ye YX; Lu XJ; Jiang H; Mao ZG; Zeng SG; Ying BW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):403-8. PubMed ID: 26121862
[TBL] [Abstract] [Full Text] [Related]
